Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 277

Similar articles for PubMed (Select 19744129)

1.

The role of microRNAs in normal and malignant hematopoiesis.

Vasilatou D, Papageorgiou S, Pappa V, Papageorgiou E, Dervenoulas J.

Eur J Haematol. 2010 Jan 1;84(1):1-16. doi: 10.1111/j.1600-0609.2009.01348.x. Epub 2009 Sep 10. Review.

PMID:
19744129
2.

MicroRNAs and haematology: small molecules, big function.

Lawrie CH.

Br J Haematol. 2007 Jun;137(6):503-12. Review.

PMID:
17539773
3.

MicroRNAs in normal and malignant hematopoiesis.

Garzon R, Croce CM.

Curr Opin Hematol. 2008 Jul;15(4):352-8. doi: 10.1097/MOH.0b013e328303e15d. Review.

PMID:
18536574
4.

MicroRNA function in cancer: oncogene or a tumor suppressor?

Shenouda SK, Alahari SK.

Cancer Metastasis Rev. 2009 Dec;28(3-4):369-78. doi: 10.1007/s10555-009-9188-5. Review.

PMID:
20012925
5.

MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, Havelange V, Volinia S, Blum W, Rush LJ, Perrotti D, Andreeff M, Bloomfield CD, Byrd JC, Chan K, Wu LC, Croce CM, Marcucci G.

Blood. 2009 Jun 18;113(25):6411-8. doi: 10.1182/blood-2008-07-170589. Epub 2009 Feb 11.

6.

MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes.

Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J.

Leuk Lymphoma. 2009 Mar;50(3):506-9. doi: 10.1080/10428190902763517.

PMID:
19347736
7.

Targeting miR-205 in breast cancer.

Wu H, Mo YY.

Expert Opin Ther Targets. 2009 Dec;13(12):1439-48. doi: 10.1517/14728220903338777. Review.

PMID:
19839716
8.
9.

MicroRNAs in benign and malignant hematopoiesis.

Bhagavathi S, Czader M.

Arch Pathol Lab Med. 2010 Sep;134(9):1276-81. doi: 10.1043/2009-0178-RS.1. Review.

PMID:
20807046
10.

[Oncogenic and tumour suppressor microRNAs].

Finoux AL, Chartrand P.

Med Sci (Paris). 2008 Dec;24(12):1049-54. doi: 10.1051/medsci/200824121049. Review. French.

11.

miR signatures and the role of miRs in acute myeloid leukaemia.

Seca H, Almeida GM, GuimarĂ£es JE, Vasconcelos MH.

Eur J Cancer. 2010 Jun;46(9):1520-7. doi: 10.1016/j.ejca.2010.03.031. Epub 2010 Apr 21. Review.

PMID:
20413298
12.

MicroRNA-146a and hemopoietic disorders.

Hua Z, Chun W, Fang-Yuan C.

Int J Hematol. 2011 Sep;94(3):224-9. doi: 10.1007/s12185-011-0923-7. Epub 2011 Sep 8. Review.

PMID:
21901398
13.

Potential therapeutic applications of miRNA-based technology in hematological malignancies.

Barbarotto E, Calin GA.

Curr Pharm Des. 2008;14(21):2040-50. Review.

PMID:
18691114
14.

MicroRNAs: small but potent oncogenes or tumor suppressors.

Lee YS, Dutta A.

Curr Opin Investig Drugs. 2006 Jun;7(6):560-4. Review.

PMID:
16784027
15.

[Expression analysis of microRNAs in erythropoiesis].

Masaki S, Ohtsuka R, Abe Y, Umemura T.

Rinsho Byori. 2008 Dec;56(12):1086-92. Japanese.

PMID:
19175072
16.

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia.

Yamanaka Y, Tagawa H, Takahashi N, Watanabe A, Guo YM, Iwamoto K, Yamashita J, Saitoh H, Kameoka Y, Shimizu N, Ichinohasama R, Sawada K.

Blood. 2009 Oct 8;114(15):3265-75. doi: 10.1182/blood-2009-06-222794. Epub 2009 Jul 29.

17.

MiR-125 in normal and malignant hematopoiesis.

Shaham L, Binder V, Gefen N, Borkhardt A, Izraeli S.

Leukemia. 2012 Sep;26(9):2011-8. doi: 10.1038/leu.2012.90. Epub 2012 Mar 29. Review.

PMID:
22456625
18.

MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.

Hummel R, Hussey DJ, Haier J.

Eur J Cancer. 2010 Jan;46(2):298-311. doi: 10.1016/j.ejca.2009.10.027. Epub 2009 Nov 28. Review.

PMID:
19948396
19.

miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.

Gandellini P, Folini M, Longoni N, Pennati M, Binda M, Colecchia M, Salvioni R, Supino R, Moretti R, Limonta P, Valdagni R, Daidone MG, Zaffaroni N.

Cancer Res. 2009 Mar 15;69(6):2287-95. doi: 10.1158/0008-5472.CAN-08-2894. Epub 2009 Feb 24.

20.

Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.

Takakura S, Mitsutake N, Nakashima M, Namba H, Saenko VA, Rogounovitch TI, Nakazawa Y, Hayashi T, Ohtsuru A, Yamashita S.

Cancer Sci. 2008 Jun;99(6):1147-54. doi: 10.1111/j.1349-7006.2008.00800.x. Epub 2008 Apr 21.

PMID:
18429962
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk